Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Riganti

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Oncoimmunology|December 12, 2013
Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stoneChiara Riganti, Massimo Massaia
International Journal of Molecular Sciences|September 29, 2019
New Strategies to Overcome Resistance to Chemotherapy and Immune System in CancerChiara Riganti, Marialessandra Contino
Cureus|April 25, 2020
Searching the Link for Better Therapeutic Combination: The Case of Tumor Cells Migration Pattern and Modality of Immunosuppression Induction at the Metastatic SiteMohamed Islam Delma, Chiara Riganti
The International Journal of Biochemistry & Cell Biology|November 9, 2020
Cholesterol metabolism: At the cross road between cancer cells and immune environmentJoanna Kopecka, Martina Godel, Chiara Riganti
Frontiers in Immunology|June 26, 2018
ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic CellsChiara Riganti, Barbara Castella, Massimo Massaia
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myelomaBarbara Castella, Chiara Riganti, Massimo Massaia
Cancers|November 26, 2022
Special Issue: "New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104)"M Helena Vasconcelos, Catherine Passirani, Chiara Riganti
Frontiers in Immunology|July 18, 2018
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune SuppressionBarbara Castella, Myriam Foglietta, Chiara Riganti, et al.
Toxicology and Applied Pharmacology|August 27, 2005
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stressChiara Riganti, Costanzo Costamagna, Amalia Bosia, et al.
European Journal of Immunology|July 19, 2012
Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?Chiara Riganti, Massimo Massaia, Martin S Davey, et al.
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Oncoimmunology|December 12, 2013
Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stoneChiara Riganti, Massimo Massaia
International Journal of Molecular Sciences|September 29, 2019
New Strategies to Overcome Resistance to Chemotherapy and Immune System in CancerChiara Riganti, Marialessandra Contino
Cureus|April 25, 2020
Searching the Link for Better Therapeutic Combination: The Case of Tumor Cells Migration Pattern and Modality of Immunosuppression Induction at the Metastatic SiteMohamed Islam Delma, Chiara Riganti
The International Journal of Biochemistry & Cell Biology|November 9, 2020
Cholesterol metabolism: At the cross road between cancer cells and immune environmentJoanna Kopecka, Martina Godel, Chiara Riganti
Frontiers in Immunology|June 26, 2018
ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic CellsChiara Riganti, Barbara Castella, Massimo Massaia
Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myelomaBarbara Castella, Chiara Riganti, Massimo Massaia
Cancers|November 26, 2022
Special Issue: "New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104)"M Helena Vasconcelos, Catherine Passirani, Chiara Riganti
Frontiers in Immunology|July 18, 2018
Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune SuppressionBarbara Castella, Myriam Foglietta, Chiara Riganti, et al.
Toxicology and Applied Pharmacology|August 27, 2005
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stressChiara Riganti, Costanzo Costamagna, Amalia Bosia, et al.
European Journal of Immunology|July 19, 2012
Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?Chiara Riganti, Massimo Massaia, Martin S Davey, et al.
Pageof 28